While infectious diseases remain a significant health problem, it has been estimated that non-communicable diseases will become the leading cause of death in Ghana by 2025. Yet despite the steadily rising incidence of cancer across sub-Saharan Africa, few medical facilities have any capacity to provide effective diagnosis and care for even the most common malignancies.

The HopeXchange Center for Cancer Screening, Diagnosis, and Treatment seeks to become the premiere hub for cancer care and research in West Africa, with state of the art diagnostic and treatment capabilities offered to all in need. Clinical Programs will focus on community based screening for common cancers, including breast, cervical, prostate and colorectal malignancies. Diagnostic services (radiology and clinical pathology) will be provided at HopeXchange to those identified through outreach screening efforts, as well as healthcare providers and facilities throughout Ghana. Treatment regimens will be developed to ensure safe and effective monitoring of both effectiveness and toxicity. Research Programs will seek to define cancer incidence within the Ashanti region, as well as establish appropriate screening methods for those cancers for which early detection leads to improved outcomes.

As a founding member of the Ghana Breast Cancer Alliance (GBCA), a consortium of local and international partners committed to raising awareness and clinical capacity in the management of breast cancer, HopeXchange promotes the importance of women’s health and the value of early cancer detection through a specially designed series of outreach and awareness programs. The programs will utilize a combination of traditional and social media to raise awareness in the community about the importance of early detection and treatment of breast and cervical cancers.